UK markets open in 2 hours 37 minutes

Epigenomics AG (EPGNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.50000.0000 (0.00%)
At close: 10:30AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
447
485
6,203
842
Cost of revenue
105
120
136
145
Gross profit
342
365
6,067
697
Operating expenses
Research development
4,496
6,191
2,941
3,659
Selling general and administrative
3,918
4,296
4,437
3,467
Total operating expenses
14,508
13,224
10,229
10,811
Operating income or loss
-14,166
-12,859
-4,162
-10,114
Interest expense
102
130
52
55
Income before tax
-16,368
-12,101
-2,410
-11,663
Income tax expense
-77
-77
18
23
Income from continuing operations
-16,291
-12,024
-2,428
-11,686
Net income
-16,291
-12,024
-2,428
-11,686
Net income available to common shareholders
-16,291
-12,024
-2,428
-11,686
Basic EPS
-19.55
-14.80
-4.35
-40.40
Diluted EPS
-19.55
-14.80
-4.35
-40.40
Basic average shares
835.738
813.322
560.37
288.933
Diluted average shares
835.738
813.322
560.37
288.933